Tanja Böhme, Elias Noory, Ulrich Beschorner, Börries Jacques, Karlheinz Bürgelin, Vincent Hofmann, Thomas Nührenberg, Franz-Josef Neumann, Thomas Zeller
OBJECTIVES: To evaluate the mortality after treatment with a paclitaxel (PTX)-coated device and with uncoated devices of iliac, femoropopliteal, and below-the-knee lesions in dialysis patients. METHODS: Retrospective mortality analysis of dialysis patients with peripheral artery disease who underwent treatment of iliac, femoropopliteal, and/or infrapopliteal lesions with PTX-coated or uncoated devices. RESULTS: Between 2010 and 2018, 1125 dialysis patients were treated with iliac and/or femoropopliteal and/or infrapopliteal lesions...
September 1, 2022: Journal of Endovascular Therapy